Internal Medicine

Discover groundbreaking FDA approvals in 2025 that redefine treatment standards, enhance patient care, and address critical public health needs.

A form of the cytisine regimen, widely used in Eastern Europe for decades, is finally being put in front of US regulators after recently also becoming available in the UK.

Yale researchers explore the risks and benefits of higher buprenorphine doses for opioid use disorder, aiming to improve treatment outcomes for veterans.

A new Yale study investigates how artificial intelligence might help identify patients at risk of developing agitation in the emergency department.

AHN is proud to offer a new, minimally invasive treatment for stress incontinence in men.

Our top 5 headlines spotlight FDA approvals for maralixibat and dupilumab, plus key trial results in diabetes, cardiovascular disease, and retinal vein occlusion.

Mindy Hoang, MD, discussed Wayne State University’s program to help clinicians understand and address underserved patients’ potential social needs.

Nawsabah Noor, MBBS, discussed how her team developed novel AI training to reduce racial bias in diagnosing mpox lesions.

Valerie Louis outlined her ASKmeGOC study and the electronic tool her team developed to help preemptively record preferences.

Zehavi Horowitz-Kugler, MD, and Ran Shaul discussed an AI model K Health developed and evaluated in a virtual urgent care clinic.

Adrienne Poon, MD, MPH, discussed early findings from a community health needs survey of AAPI populations.

Our top 5 headlines spotlight developments in AI-driven care, diabetes tech, and dermatology, alongside key FDA actions in ophthalmology and nephrology.

Gelles discussed AI tools that are becoming a part of clinician’s armamentariums and the impact they are having on the field.